fbpx
May 13, 2022

‘Twincretin’ Tirzepatide Gets FDA Approval for Type 2 Diabetes ‘Twincretin’ Tirzepatide Gets FDA Approval for Type 2 Diabetes

The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s approval of tirzepatide for this indication on […]
May 13, 2022

Tirzepatide (Mounjaro) Gets FDA Approval for Type 2 Diabetes Tirzepatide (Mounjaro) Gets FDA Approval for Type 2 Diabetes

The “Twincretin” era for treating patients with type 2 diabetes has begun, with the US Food and Drug Administration’s (FDA’s) approval of tirzepatide for this indication […]
May 13, 2022

RaDonda Vaught Sentenced to Probation for Patient Death RaDonda Vaught Sentenced to Probation for Patient Death

Calling the death of 75-year-old patient Charlene Murphey a “terrible, terrible mistake,” a Tennessee judge sentenced former nurse RaDonda Vaught, RN, to 3 years of supervised […]
May 13, 2022

FDA Approves Medtronic’s Onyx Frontier Drug-Eluting Stent FDA Approves Medtronic’s Onyx Frontier Drug-Eluting Stent

The US Food and Drug Administration (FDA) has approved the Onyx Frontier drug-eluting stent (DES) to treat patients with coronary artery disease, the device manufacturer, Medtronic, […]
May 13, 2022

FDA Approves Oral Form of ALS Drug Edaravone FDA Approves Oral Form of ALS Drug Edaravone

The US Food and Drug Administration (FDA) has approved an orally administered version of edaravone (Radicava ORS) for adults with amyotrophic lateral sclerosis (ALS).  Edaravone is […]
May 6, 2022

Potential Risk From Fresenius Dialysis Units, FDA Warns Potential Risk From Fresenius Dialysis Units, FDA Warns

The US Food and Drug Administration (FDA) today warned clinicians of a potential risk for patient exposure to toxic compounds associated with the use of certain […]
May 5, 2022

FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer

The US Food and Drug Administration (FDA) has granted standard approval to fam-trastuzumab deruxtecan-nxki (Enhertu) for patients with unresectable or metastatic HER2-positive breast cancer who have […]
May 4, 2022

FDA Clears Diagnostic Test for Early Alzheimer’s FDA Clears Diagnostic Test for Early Alzheimer’s

The US Food and Drug Administration (FDA) has cleared the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD) The Lumipulse […]
May 4, 2022

FDA Approves Two Vonoprazan Therapies for H pylori Eradication FDA Approves Two Vonoprazan Therapies for H pylori Eradication

The US Food and Drug Administration (FDA) has approved two vonoprazan-based treatments for Helicobacter pylori infection: Voquezna Triple Pak (vonoprazan, amoxicillin, clarithromycin) and Voquezna Dual Pak […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0